Publikationen von Luis A. Pardo
Alle Typen
Zeitschriftenartikel (99)
61.
Zeitschriftenartikel
6 (10), e26329 (2011)
Rapid internalization of the oncogenic K+ channel Kv10.1. PLoS ONE 62.
Zeitschriftenartikel
10, 109 (2011)
Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody. Molecular Cancer 63.
Zeitschriftenartikel
6 (5), e19257 (2011)
Functional KV10.1 channels localize to the inner nuclear membrane. PLoS ONE 64.
Zeitschriftenartikel
3 (6), S. 309 - 319 (2011)
A CAG repeat polymorphism of KCNN3 predicts SK3 channel function and cognitive performance in schizophrenia. Embo Molecular Medicine 65.
Zeitschriftenartikel
9, 18 (2010)
The potassium channel Ether a go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia. Molecular Cancer 66.
Zeitschriftenartikel
5 (1), e8858 (2010)
Characterization of Eag1 channel lateral mobility in rat hippocampal cultures by single-particle-tracking with quantum dots. PLoS ONE 67.
Zeitschriftenartikel
9 (2), S. 918 - 924 (2010)
EAG1, EAG2 and KCNN3 gene brain expression of isolated reared rats. Genes, Brain and Behavior 68.
Zeitschriftenartikel
2 (5), S. 745 - 755 (2010)
K+ channels as therapeutic targets in oncology. Future Medicinal Chemistry 69.
Zeitschriftenartikel
8, S. 982 - 1001 (2009)
Voltage-gated potassium channels as therapeutic targets. Nature Reviews Drug Discovery 70.
Zeitschriftenartikel
70 (2), S. 286 - 293 (2009)
Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice. European Journal of Radiology 71.
Zeitschriftenartikel
38 (3), S. 279 - 284 (2009)
The voltage dependence of hEag currents is not determined solely by membrane-spanning domains. European Biophysics Journal 72.
Zeitschriftenartikel
283 (52), S. 36234 - 36240 (2008)
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors. Journal of Biological Chemistry 73.
Zeitschriftenartikel
68 (6), S. 1611 - 1613 (2008)
Eag1: an emerging oncological target. Cancer Research 74.
Zeitschriftenartikel
9 (6), S. 512 - 515 (2008)
Ion channels: functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Reports 75.
Zeitschriftenartikel
30, S. 162 - 173 (2008)
Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neurobiology of Disease 76.
Zeitschriftenartikel
155, S. 833 - 844 (2008)
Eag1 potassium channel immunohistochemistry in the CNS of adult rat and selected regions of human brain. Neuroscience 77.
Zeitschriftenartikel
12 (7), S. 837 - 843 (2008)
Eag1 as a cancer target. Expert Opinion on Therapeutic Targets 78.
Zeitschriftenartikel
67 (15), S. 7343 - 7349 (2007)
Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Research 79.
Zeitschriftenartikel
171 (2), S. 589 - 598 (2007)
Re-expression of a developmentally restricted potassium channel in autoimmune demyelination - Kv1.4 is implicated in oligodendroglial proliferation. American Journal of Pathology 80.
Zeitschriftenartikel
5, 41 (2006)
Overexpression of EagI potassium channels in clinical tumours. Molecular Cancer